Artificial Intelligence in Healthcare Diagnosis Market Report 2024 - Market Size, Growth Rate, Major Drivers And Key Trends | Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation

"The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $16.28 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 44.9%. The growth in the historic period can be attributed to advancements in medical imaging, data accessibility and digitization, clinical workflow optimization, research and development investments, shortage of healthcare professionals.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $104.32 billion in 2028 at a compound annual growth rate (CAGR) of 45.0%. The growth in the forecast period can be attributed to ai-powered precision medicine, integration with electronic health records, expansion of medical imaging analysis, rise of wearable health tech, regulatory support and standards. Major trends in the forecast period include explainable ai in healthcare, ai-driven early disease detection, telehealth integration, ai in pathology and histopathology, ai-enabled point-of-care diagnostics.

Market Overview -
Artificial intelligence (AI) in healthcare diagnosis refers to applying AI techniques, such as machine learning and deep learning algorithms, to diagnose medical conditions. It is employed to evaluate data, including clinical trials, medical records, and genetic information, that can aid medical practitioners in making a diagnosis much more quickly than any human could.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12609&type=smp

Navigating The Rise In Chronic Diseases With Ai-Driven Diagnosis
The rising incidence rate of chronic diseases is expected to propel the growth of artificial intelligence in the healthcare diagnosis market going forward. Chronic diseases are long-term health conditions that generally progress slowly over time and often persist intermittently. Artificial Intelligence (AI) in healthcare diagnosis has the potential to significantly impact the management and diagnosis of chronic diseases as it can aid in cost savings and improved resource use. It can help medical practitioners make better decisions, spot patients in danger, and give more individualized care. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising incidence rate of chronic diseases is driving the growth of artificial intelligence in the healthcare diagnosis market.

Competitive Landscape -
Major companies operating in the artificial intelligence in healthcare diagnosis market report are Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Caption Health, Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

Innovations In AI Technologies For Healthcare Diagnosis Leadership
Technological advancement is a key trend gaining popularity in artificial intelligence in the healthcare diagnosis market. Major companies operating in artificial intelligence in the healthcare diagnosis market are concentrating on creating innovative technologies to sustain their position in the market. For instance, in March 2023, Genomic Vision, a France-based biotechnology company, launched FiberSmart, an AI-powered software to automate detecting and quantifying fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. FiberSmart offers a simple and user-friendly interface, allowing fast analysis of DNA replication signals to deduce essential parameters describing replication kinetics. Compared to Genomic Vision's current software solutions, the program uses advanced AI techniques to visualize, detect, and evaluate DNA replication kinetics up to three times more accurately and up to ten times faster. FiberSmart's user-friendly interface and ergonomic design enable quick analysis of DNA replication signals to determine crucial variables describing replication kinetics.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Key Segments -
The artificial intelligence in healthcare diagnosis market covered in this report is segmented -
1) By Component: Software, Services, Hardware
2) By Diagnosis: Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses
3) By Modality: MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound
4) By Application: In Vivo Diagnostics, In Vitro Diagnostics
5) By End-User: Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.